Status: Recruiting
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for leukemia compared to individuals who do not receive TKI therapy.
Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of Rochester NCORP Research BaseUpdated: Jun 10, 2026Locations: 1
Eligibility criteria
TKI RECIPIENTS: Participants must have a diagnosis of CML or CLL [+8]
Participants must have no history of metastatic cancer, primary brain tumor, or... [+9]